Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

265 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection.
Corey GR, Wilcox M, Talbot GH, Friedland HD, Baculik T, Witherell GW, Critchley I, Das AF, Thye D. Corey GR, et al. Clin Infect Dis. 2010 Sep 15;51(6):641-50. doi: 10.1086/655827. Clin Infect Dis. 2010. PMID: 20695801 Clinical Trial.
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens.
Rubinstein E, Lalani T, Corey GR, Kanafani ZA, Nannini EC, Rocha MG, Rahav G, Niederman MS, Kollef MH, Shorr AF, Lee PC, Lentnek AL, Luna CM, Fagon JY, Torres A, Kitt MM, Genter FC, Barriere SL, Friedland HD, Stryjewski ME; ATTAIN Study Group. Rubinstein E, et al. Among authors: corey gr. Clin Infect Dis. 2011 Jan 1;52(1):31-40. doi: 10.1093/cid/ciq031. Clin Infect Dis. 2011. PMID: 21148517 Free PMC article. Clinical Trial.
Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.
Stryjewski ME, Barriere SL, Rubinstein E, Genter FC, Lentnek AL, Magana-Aquino M, Luna CM, Niederman MS, Torres A, Corey GR. Stryjewski ME, et al. Among authors: corey gr. Int J Antimicrob Agents. 2013 Oct;42(4):367-9. doi: 10.1016/j.ijantimicag.2013.06.003. Epub 2013 Jul 26. Int J Antimicrob Agents. 2013. PMID: 23891527 No abstract available.
Assessment of telavancin minimal inhibitory concentrations by revised broth microdilution method in phase 3 complicated skin and skin-structure infection clinical trial isolates.
Smart JI, Corey GR, Stryjewski ME, Wang W, Barriere SL. Smart JI, et al. Among authors: corey gr. Diagn Microbiol Infect Dis. 2017 Mar;87(3):268-271. doi: 10.1016/j.diagmicrobio.2016.12.009. Epub 2016 Dec 14. Diagn Microbiol Infect Dis. 2017. PMID: 28038840 Free article. Clinical Trial.
A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive Pathogens.
Huang DB, File TM Jr, Torres A, Shorr AF, Wilcox MH, Hadvary P, Dryden M, Corey GR. Huang DB, et al. Among authors: corey gr. Clin Ther. 2017 Aug;39(8):1706-1718. doi: 10.1016/j.clinthera.2017.07.007. Epub 2017 Jul 27. Clin Ther. 2017. PMID: 28756068 Free article. Clinical Trial.
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1.
Huang DB, O'Riordan W, Overcash JS, Heller B, Amin F, File TM, Wilcox MH, Torres A, Dryden M, Holland TL, McLeroth P, Shukla R, Corey GR. Huang DB, et al. Among authors: corey gr. Clin Infect Dis. 2018 Apr 3;66(8):1222-1229. doi: 10.1093/cid/cix987. Clin Infect Dis. 2018. PMID: 29281036 Free article. Clinical Trial.
265 results